Clinical Trial Site

Monterrey 64460

1 studies enrolling now · 2 studies all time

What they study most

Advanced Breast Cancer, Amyloidosis, Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, Leukocyte Chemotactic Factor 2 Amyloidosis, Metastatic Breast Cancer

Studies at this site

• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease — Stopped early